← All trials
NCT04687761
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 4, 2020
- Primary completion
- Nov 30, 2024
- Completion date
- Nov 30, 2024
- First posted
- Dec 29, 2020
- Last posted
- Dec 29, 2020
- Enrollment
- 84
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- PETHEMA FoundationLead sponsor
- University of ValenciaOverall official - principal investigator
- Hospital San Pedro de AlcantaraOverall official - principal investigator
- PETHEMA FoundationStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.